Skip to main content
Article thumbnail
Location of Repository

Olopatadine ophthalmic solution suppresses substance P release in the conjunctivitis models

By Tadafumi Tamura
Topics: Original Article
Publisher: Asia Pacific Association of Allergy, Asthma and Clinical Immunology
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. Active bronchial anaphylaxis in the rat.
    2. (1996). Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.
    3. (1997). Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells. Ann Allergy Asthma Immunol
    4. (1998). Cutaneous innervation and the role of neuronal peptides in cutaneous inflammation: a minireview.
    5. Elevated levels of substance P in tears of patients with allergic conjunctivitis and vernal keratoconjunctivitis. Clin Exp Allergy Olopatadine drop suppresses substance P release
    6. Histamine release and vascular changes induced by neuropeptides.
    7. Increasing effect by simultaneous use of levocabastine and pemirolast on experimental allergic conjunctivitis in rats.
    8. (1999). Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs.
    9. Neurogenic inflammation of the ocular surface.
    10. (1996). Olopatadine (AL-4943A): ligand binding and functional studies on a novel, long acting H1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitis.
    11. Olopatadine hydrochloride improves dermatitis score and inhibits scratch behavior in NC/Nga mice.
    12. Pathophysiology of itch and new treatments.
    13. Preseasonal treatment with topical olopatadine suppresses the clinical symptoms of seasonal allergic conjunctivitis.
    14. (1993). Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients.
    15. The effects of olopatadine hydrochloride on the number of scratching induced by repeated application of oxazolone in mice.
    16. (1996). The in vitro and in vivo ocular pharmacology of olopatadine (AL4943A), an effective anti-allergic/antihistaminic agent.
    17. The role of neuromediators in ocular allergy.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.